Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT

NCT06183047 · clinicaltrials.gov ↗

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Early Release of Chromogranin A (CgA)

Interventions

DIAGNOSTIC_TEST: early release of chromogranin A (CgA) in patients with neuroendocrine tumours (NET) treated with peptide receptor radionuclide therapy (PRRT).

Sponsor

Military Institute od Medicine National Research Institute